Montecito Bank & Trust reports growth in assets, deposits and income
Montecito Bank & Trust saw its total assets grow more than 20% during 2020, on the back of strong loan production, deposit growth and higher net income, the bank said Feb. 5. The bank’s total assets grew $344.1 million, a boost of about 21.4% from the previous year, bringing Montecito Bank & Trust’s total assets Read More →
Read More →Amgen shares slip after projections of flat 2021 sales
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →PennyMac reports earnings jump, tops $2B in income in 2020
PennyMac Financial Services hit a record high with pretax income of more than $2 billion last year as the company saw a sharp increase in both its fourth quarter and year-end results. The Westlake Village-based mortgage firm reported a net income of $452.8 million for the fourth quarter of 2020, or $5.97 per share on Read More →
Read More →Amgen reports rising revenue, warns of flat 2021
Amgen, one of the world’s largest biotech companies, saw rising revenue in the fourth quarter of 2020, but the COVID-19 pandemic could dampen the outlook for the company and its investors in 2021, according to earnings released Feb. 2. The Thousand Oaks-based biotech firm had $6.6 billion in revenue in the fourth quarter, a 7% Read More →
Read More →Inphi reports record revenue, declining losses in 2020
Inphi, a Santa Clara semiconductor company with sizable operations in Thousand Oaks, reported record revenue for the fourth quarter of 2020 and a smaller net loss than the same quarter a year earlier. Inphi, which reported its earnings on Feb. 2, is in the midst of being acquired by Marvell Technology Group, a larger competitor Read More →
Read More →Arcutis stock soars on drug trial news; company announces $150M capital raise
Stock of Arcutis Biotherapeutics, a Westlake Village-based company developing dermatological treatments, shot up more than 30% on Feb. 1 after the company released positive results from a recent clinical trial. Later in the day, Arcutis said it plans to sell $150 million worth of its common stock. Before stock trading opened, the company announced positive Read More →
Read More →